Integrated Partnerships for Enabling Agility in Biologics Development

As biologic modalities grow more complex and timelines compress, the operational relationship between contract development and manufacturing organizations ...

February 26, 2026 | Thursday | Opinion
ImmunityBio Expands Global Footprint with ANKTIVA Commercialization Partnership in Middle East

Biopharma & Cigalah are two of the largest pharmaceutical commercial distributors in the Middle East and North Africa (MENA) ImmunityBio establi...

February 24, 2026 | Tuesday | News
Dr. Reddy’s Advances Biosimilar Pipeline with FDA Review Acceptance for DRL_AB

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “D...

February 24, 2026 | Tuesday | News
Hana Health by DSS Imagetech Partners with Overture Life to Introduce Automated Egg-Freezing Technology in India

For the first time in India, couples seeking In Vitro Fertilisation (IVF) treatment for conception can rely on a globally preferred, automated egg-freezi...

February 20, 2026 | Friday | News
Andelyn Biosciences Expands Commitment to Rare Disease Community with NKH Gene Therapy Manufacturing Program

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selecte...

February 19, 2026 | Thursday | News
Newron Pharmaceuticals S.p.A. Secures Up to €38 Million to Accelerate Phase III Evenamide Program in Treatment-Resistant Schizophrenia

Proceeds expected to fund global ENIGMA-TRS studies and extend cash runway beyond pivotal 12-week results, supporting development of evenamide as the p...

February 18, 2026 | Wednesday | News
Christopher Cargill Positions Nxera Pharma Co., Ltd. for Scalable Growth and Profitability Following Strategic Pipeline and Commercial Expansion in 2025

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolid...

February 17, 2026 | Tuesday | Company results
InnoCare Pharma Doses First Patient in Phase II/III Trial of Soficitinib for Chronic Spontaneous Urticaria

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced &nb...

February 17, 2026 | Tuesday | News
Norman Schwartz Charts Performance Reset for Bio-Rad Laboratories, Inc. After Turbulent 2025

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced financial results for the fourth quarte...

February 16, 2026 | Monday | Company results
Sanofi Appoints Belén Garijo as CEO, Signaling Bold Leadership Shift to Strengthen Innovation and Performance

Belén Garijo to become Chief Executive Officer of Sanofi Sanofi's Board of Directors met on February 11, 2026, and decided not to renew the Direc...

February 13, 2026 | Friday | News
CEO Daniel O’Day Underscores Strength of Gilead’s HIV Franchise After Solid 2025 Results

  Product Sales Excluding Veklury Increased 4% Year-Over-Year to $28.0 billion for Full Year 2025 Biktarvy Sales Increased 7% Year-Over-Year to $1...

February 12, 2026 | Thursday | Company results
FUJIFILM Biotechnologies Opens £400M UK Biomanufacturing Expansion in Teesside

FUJIFILM Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing innovativ...

February 12, 2026 | Thursday | News
Novartis Expands US Innovation Footprint with USD 23 Billion R&D Push, Including New San Diego Research Hub

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including C...

February 09, 2026 | Monday | News
Slingshot Biosciences Strengthens UK and EU Presence with Synthetic Cell Mimic Technology

Life sciences innovator and leader in precision-engineered synthetic cell mimic technology expands its UK/EU operations to accelerate cell and gene thera...

February 06, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close